The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study

The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study

(2016) F. Gossiel et al.   BONE

Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women

(2016) Yejee Lim et al.   CALCIFIED TISSUE INTERNATIONAL

Haemophilia and low bone mass. Ok, but what about fracture risk?

(2016) P. Anagnostis et al.   HAEMOPHILIA

High serum sclerostin levels in children with haemophilia A

(2015) Paola Giordano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Ibandronate Increases Sclerostin Levels and Bone Strength in Male Patients with Idiopathic Osteoporosis

(2015) Christian Muschitz et al.   CALCIFIED TISSUE INTERNATIONAL

Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women

(2014) S. Gonnelli et al.   BONE

Serum Levels of Sclerostin and Dickkopf-1: Effects of Age, Gender and Fracture Status

(2014) Peter Dovjak et al.   GERONTOLOGY

Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?

(2014) R. Sapir-Koren et al.   OSTEOPOROSIS INTERNATIONAL

Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis

(2014) S. A. Paschou et al.   OSTEOPOROSIS INTERNATIONAL

Developments in Sclerostin Biology: Regulation of Gene Expression, Mechanisms of Action, and Physiological Functions

(2014) Megan M. Weivoda et al.   Current Osteoporosis Reports

The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B

(2013) P. Anagnostis et al.   HAEMOPHILIA

Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2

(2013) Masakazu Kogawa et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture

(2013) Timoleon-Achilleas Vyzantiadis et al.   THROMBOSIS AND HAEMOSTASIS

Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases

(2013) E. Michael Lewiecki   Therapeutic Advances in Musculoskeletal Disease

High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study

(2012) Mohammed-Salleh M Ardawi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women

(2012) Aarthi Arasu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

RANK-RANKL-OPG in Hemophilic Arthropathy: From Clinical and Imaging Diagnosis to Histopathology

(2012) DANIELA MELCHIORRE et al.   JOURNAL OF RHEUMATOLOGY

Reduced bone mineral density in patients with haemophilia A and B in Northern Greece

(2012) Sofia Vakalopoulou et al.   THROMBOSIS AND HAEMOSTASIS

Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading

(2011) Xiaolin Tu et al.   BONE

Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia

(2010) Athanasios Christoforidis et al.   ANNALS OF HEMATOLOGY

Bone Status of Children With Hemophilia A Assessed With Quantitative Ultrasound Sonography (QUS) and Dual Energy X-ray Absorptiometry (DXA)

(2010) Athanasios Christoforidis et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Bone mineral density in haemophilia patients

(2010) Gianluigi Fabbriciani et al.   THROMBOSIS AND HAEMOSTASIS

Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection

(2009) Olga Katsarou et al.   ANNALS OF HEMATOLOGY

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

The Effect of Zoledronic Acid on Serum Dickkopf-1, Osteoprotegerin, and RANKL in Patients with Paget's Disease of Bone

(2009) S. A. Polyzos et al.   HORMONE AND METABOLIC RESEARCH

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL